Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative

BACKGROUND: Active surveillance (AS) is a management option for men diagnosed with low-risk prostate cancer. Opinions differ on whether it is safe to include young men (≤60 yr) or men with intermediate-risk disease. OBJECTIVE: To assess whether reasons for discontinuation, treatment choice after AS,...

Descripción completa

Detalles Bibliográficos
Autores principales: Remmers, Sebastiaan, Helleman, Jozien, Nieboer, Daan, Trock, Bruce, Hyndman, Matthew E., Moore, Caroline M., Gnanapragasam, Vincent, Shiong Lee, Lui, Elhage, Oussama, Klotz, Laurence, Carroll, Peter, Pickles, Tom, Bjartell, Anders, Robert, Grégoire, Frydenberg, Mark, Sugimoto, Mikio, Ehdaie, Behfar, Morgan, Todd M., Rubio-Briones, Jose, Semjonow, Axel, Bangma, Chris H., Roobol, Monique J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Prostate Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257656/
https://www.ncbi.nlm.nih.gov/pubmed/35813247
http://dx.doi.org/10.1016/j.euros.2022.05.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257656/
https://www.ncbi.nlm.nih.gov/pubmed/35813247
http://dx.doi.org/10.1016/j.euros.2022.05.012

Ejemplares similares